ATE407702T1 - Liposomale einkapselung von alphastrahlern, und deren verwendung - Google Patents
Liposomale einkapselung von alphastrahlern, und deren verwendungInfo
- Publication number
- ATE407702T1 ATE407702T1 AT01942205T AT01942205T ATE407702T1 AT E407702 T1 ATE407702 T1 AT E407702T1 AT 01942205 T AT01942205 T AT 01942205T AT 01942205 T AT01942205 T AT 01942205T AT E407702 T1 ATE407702 T1 AT E407702T1
- Authority
- AT
- Austria
- Prior art keywords
- alphast
- emitters
- liposomal encapsulation
- emitting
- radionuclides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
- A61K51/1234—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Glass Compositions (AREA)
- Dental Preparations (AREA)
- External Artificial Organs (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21218600P | 2000-06-16 | 2000-06-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE407702T1 true ATE407702T1 (de) | 2008-09-15 |
Family
ID=22789922
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01942205T ATE407702T1 (de) | 2000-06-16 | 2001-06-15 | Liposomale einkapselung von alphastrahlern, und deren verwendung |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20030175206A1 (de) |
| EP (1) | EP1289570B1 (de) |
| JP (1) | JP2003535913A (de) |
| AT (1) | ATE407702T1 (de) |
| AU (2) | AU7548901A (de) |
| CA (1) | CA2411826A1 (de) |
| DE (1) | DE60135743D1 (de) |
| ES (1) | ES2312448T3 (de) |
| WO (1) | WO2001097859A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2422291C (en) * | 2000-09-15 | 2011-03-08 | Sloan-Kettering Institute For Cancer Research | Targeted alpha particle therapy using actinium-225 conjugates |
| WO2005086639A2 (en) * | 2004-02-10 | 2005-09-22 | Barnes-Jewish Hospital | Improved efficacy and safety of targeted particulate agents with decoy systems |
| GB0423565D0 (en) * | 2004-10-22 | 2004-11-24 | Algeta As | Formulation |
| TW200922630A (en) * | 2007-09-26 | 2009-06-01 | Nat Health Research Institutes | Liposome compositions useful for tumor imaging and treatment |
| EP3773996A4 (de) | 2018-03-26 | 2022-03-30 | Triumf | Systeme, vorrichtung und verfahren zur trennung von actinium, radium und thorium |
| KR20210087949A (ko) * | 2018-11-01 | 2021-07-13 | 알파 타우 메디컬 리미티드 | 종양내 알파-방출체 방사선 및 세포내 병원체에 대한 세포질 센서의 활성화 |
| EP3917499A4 (de) * | 2019-01-29 | 2022-10-19 | The Johns Hopkins University | Adhäsions-/adsorptionsschalter auf nanoteilchen zur erhöhung der tumoraufnahme und zur verzögerung von tumor-clearance |
| US20230241256A1 (en) * | 2020-06-30 | 2023-08-03 | The Johns Hopkins University | Non-intuitive combination of drug delivery carriers of the same drug for synergistic growth delay of solid tumors |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4394372A (en) * | 1980-12-22 | 1983-07-19 | The Procter & Gamble Company | Process for making lipid membrane structures |
| US4624846A (en) * | 1983-07-29 | 1986-11-25 | Immunomedics, Inc. | Method for enhancing target specificity of antibody localization and clearance of non-target diagnostic and therapeutic principles |
| US4671256A (en) * | 1984-05-25 | 1987-06-09 | Lemelson Jerome H | Medical scanning, monitoring and treatment system and method |
| US5328678A (en) * | 1987-11-04 | 1994-07-12 | Vestar, Inc. | Composition and method of use for liposome encapsulated compounds for neutron capture tumor therapy |
| US5807572A (en) * | 1988-02-18 | 1998-09-15 | Depotech Corporation | Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride |
| CA2034484C (en) * | 1989-06-19 | 2000-08-15 | Maurits W. Geerlings | Radioimmunotherapy using .alpha.-particles emission |
| US5585112A (en) * | 1989-12-22 | 1996-12-17 | Imarx Pharmaceutical Corp. | Method of preparing gas and gaseous precursor-filled microspheres |
| US5534241A (en) * | 1993-07-23 | 1996-07-09 | Torchilin; Vladimir P. | Amphipathic polychelating compounds and methods of use |
| US5662929A (en) * | 1994-12-23 | 1997-09-02 | Universite De Montreal | Therapeutic liposomal formulation |
| US6322810B1 (en) * | 1997-07-14 | 2001-11-27 | Hayat Alkan-Onyuksel | Materials and methods for making improved micelle compositions |
| US6060315A (en) * | 1997-12-01 | 2000-05-09 | Lockheed Martin Energy Research Corporation | Method for facilitating the introduction of material into cells |
| NO312708B1 (no) * | 2000-02-21 | 2002-06-24 | Anticancer Therapeutic Inv Sa | Radioaktive liposomer til terapi |
-
2001
- 2001-06-15 AU AU7548901A patent/AU7548901A/xx active Pending
- 2001-06-15 CA CA002411826A patent/CA2411826A1/en not_active Abandoned
- 2001-06-15 AT AT01942205T patent/ATE407702T1/de not_active IP Right Cessation
- 2001-06-15 JP JP2002503342A patent/JP2003535913A/ja active Pending
- 2001-06-15 ES ES01942205T patent/ES2312448T3/es not_active Expired - Lifetime
- 2001-06-15 AU AU2001275489A patent/AU2001275489B2/en not_active Ceased
- 2001-06-15 DE DE60135743T patent/DE60135743D1/de not_active Expired - Fee Related
- 2001-06-15 WO PCT/US2001/019133 patent/WO2001097859A1/en not_active Ceased
- 2001-06-15 EP EP01942205A patent/EP1289570B1/de not_active Expired - Lifetime
-
2002
- 2002-12-16 US US10/319,978 patent/US20030175206A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20030175206A1 (en) | 2003-09-18 |
| WO2001097859A1 (en) | 2001-12-27 |
| CA2411826A1 (en) | 2001-12-27 |
| ES2312448T3 (es) | 2009-03-01 |
| JP2003535913A (ja) | 2003-12-02 |
| AU7548901A (en) | 2002-01-02 |
| EP1289570A4 (de) | 2004-12-15 |
| EP1289570A1 (de) | 2003-03-12 |
| AU2001275489B2 (en) | 2005-01-27 |
| EP1289570B1 (de) | 2008-09-10 |
| DE60135743D1 (de) | 2008-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60219627D1 (de) | Nachweis und therapie von empfindlichem plaque mit photodynamischen verbindungen | |
| DK0960107T3 (da) | 6-Thiosubstituerede paclitaxeler | |
| TR200002355T2 (tr) | 2-(Pürin-9-il)tetrahidrofüran-3,4-diol türevleri | |
| ES2194180T3 (es) | Nuevas fenantridinas. | |
| PL371736A1 (en) | Method for administering glp-1 molecules | |
| FI951138A7 (fi) | Puuttellisia adenovirusvektoreita ja niiden käyttö geeniterapiassa | |
| ATE294595T1 (de) | Radioaktive zusammensetzungen zur behandlung von prostatatumoren | |
| CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
| DK1104425T3 (da) | Hidtil ukendte thiazolopyrimidinforbindelser | |
| DE59708265D1 (de) | Neue in 6-position substituierte phenanthridine | |
| PT998460E (pt) | Novos derivados de tetrazole | |
| NO331082B1 (no) | Formulering av kahalalid F, sett omfattende en slik formulering, samt rekonstituert losning derav og anvendelse av en fortynnet rekonstituert losning til fremstilling av et medikament for behandling av kreft | |
| DE60135743D1 (de) | Liposomale einkapselung von alphastrahlern, und deren verwendung | |
| TR200402030T4 (tr) | İkame edilen I-aminobutan-3-ol-türevleri | |
| DE69831737D1 (de) | Neurotrypsin | |
| ATE411036T1 (de) | Verwendung von aplidine in der behandlung von pankreaskrebs | |
| ATE335824T1 (de) | Isolierte luziferasen sowie deren verwendung | |
| DE60124148D1 (de) | Kalzilytische verbindungen | |
| DK1011329T3 (da) | 7-Methylthiooxomethyl- og 7-methylthiodioxomethyl-paclitaxeler | |
| DE69937797D1 (de) | Alpha-emittierende konstrukte sowie deren verwendung | |
| NO20024587L (no) | Forbindelser med (celle-) mÕlsökende evne | |
| TR200103662T2 (tr) | Yeni kalpainler ve bunların kullanılması | |
| ES2170479T3 (es) | Agente viral terapeutico que detiene el desarrollo de tumores. | |
| PT980379E (pt) | Oligonucleotidos quimericos e sua utilizacao | |
| DE50211461D1 (de) | Pharmazeutische zusammensetzung enthaltend bulbophyllum |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |